Skip to content

The Water Drinking Test in Glaucoma Study

The Water Drinking Test in Glaucoma Study

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05283031
Acronym
WIGS
Enrollment
46
Registered
2022-03-16
Start date
2021-03-17
Completion date
2021-06-09
Last updated
2024-09-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Glaucoma

Keywords

Intraocular Pressure, Stress Test, Correlation, Water Drinking Test, OCT, Normal Tension Glaucoma

Brief summary

To investigate the correlation and agreement between the intraocular pressure peaks detected during the water drinking test and modified diurnal tension curve in glaucomatous eyes and to analyse whether this is associated with prognostic outcome. The study will also measure autonomic nervous system activation during the test to investigate one possible mechanism behind it.

Detailed description

Glaucoma is a progressive optic neuropathy characterized by progressive loss of retinal ganglion cells, leading to thinning of the retinal nerve fiber layer and visual field losses. It is the leading cause of irreversible blindness in the world \[2\] and affects more than 70 million people worldwide. Intraocular pressure (IOP) is the main risk factor for the development and progression of glaucoma. The gold standard for intraocular pressure (IOP) measurement is applanation tonometry. Routine office measurements may not detect IOP peaks in roughly 30% of patients due to variation throughout the day and this detection failure may be responsible for visual field progression in apparently well-controlled patients. Therefore this study is to investigate the correlation and agreement between the intraocular pressure peaks detected during the water drinking test and modified diurnal tension curve in glaucomatous eyes and to analyze whether this is associated with prognostic outcome. The study will also measure autonomic nervous system activation during the test to investigate one possible mechanism behind it. The primary measure is peak Intraocular pressure measurements from two different measures. Secondary measures include OCT angiography, postural blood pressure, heart rate, pupil diameter. Current and future rates of progression using visual field and optical coherence tomography (OCT) measures. This is a prospective method comparison study, of 40 primary open angle and normal tension glaucoma patients who will attend for a single visit. Inclusion criteria include those * Able to give informed consent to participate in the study * Aged between 18 and 80 years of age * Clear optical media * Spherical equivalent +-10 Dioptres * Normal tension glaucoma proven by visual field testing or OCT imaging combined with clinical assessment. * Primary open angle glaucoma proven by visual field testing or OCT imaging combined with clinical assessment Following completion of the study, participants will be followed up in their usual clinic as part of their regular care. The participants' follow-up data which is routinely generated as part of the glaucoma care pathway will be accessed for 18 months following completion of participation with a view of correlating initial results with possible disease progression and other related outcomes.

Interventions

DIAGNOSTIC_TESTModified Diurnal Tension Curve

The modified diurnal tension curve (mDTC), an alternative that involves IOP measurements every 2 or 3 hours during office hours, is more feasible and may provide better information regarding the IOP profile than single IOP measurements.

Sponsors

Imperial College London
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
Yes

Inclusion criteria

* Able to give informed consent to participate in the study * Aged between 18 and 80 years of age * Clear optical media * Spherical equivalent +-10 Dioptres * Normal tension glaucoma proven by visual field testing or OCT imaging combined with clinical assessment. * Primary open angle glaucoma proven by visual field testing or OCT imaging combined with clinical assessment.

Exclusion criteria

* Are using ocular hypotensive therapy, or have done so in the last 30 days * Have any other known ocular disease (except glaucoma) * Have serious cardiac or kidney disease (WDT contra-indication) * Have swallowing difficulties associated with either a neurological or gastrointestinal condition. * Patients with any contra-indication of drinking large amounts of water in a small period of time e.g. swallowing impairment, oesophageal stricture, gastric banding. * Have secondary or narrow/closed angle glaucoma * Patients submitted to any surgical procedure or laser intervention during the evaluation period

Design outcomes

Primary

MeasureTime frameDescription
Maximum Intraocular Pressure Difference (Between mDCT and WDT)Single measurement (mDCT 5 measurements taken one every 2 hours and WDT a measurement taken every 15 minutes up to 45 minutes)Maximum intraocular pressure difference between two methods applied to each subject (modified diurnal tension curve mDTC and water drinking test WDT). The difference between maximum intraocular pressure of five eye pressure measurements taken at 8:00, 10:00, 12:00, 14:00 and 16:00 minus the maximum intraocular pressure measured at 15 minute intervals over 45 minutes during the water drinking test.

Countries

United Kingdom

Participant flow

Participants by arm

ArmCount
Glaucoma Patients
Those included in the study were male or female participants between the ages of 18 to 80 years old with a diagnosis of POAG or NTG in either eye.
42
Total42

Baseline characteristics

CharacteristicGlaucoma Patients
Age, Continuous65.5 years
STANDARD_DEVIATION 9.04
Mean baseline IOP (± SD)14.9 mmHg
STANDARD_DEVIATION 4.5
Mean visual field mean deviation-5.05 dB
STANDARD_DEVIATION 5.45
Race and Ethnicity Not Collected— Participants
Region of Enrollment
United Kingdom
42 participants
Sex: Female, Male
Female
22 Participants
Sex: Female, Male
Male
20 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 42
other
Total, other adverse events
0 / 42
serious
Total, serious adverse events
0 / 42

Outcome results

Primary

Maximum Intraocular Pressure Difference (Between mDCT and WDT)

Maximum intraocular pressure difference between two methods applied to each subject (modified diurnal tension curve mDTC and water drinking test WDT). The difference between maximum intraocular pressure of five eye pressure measurements taken at 8:00, 10:00, 12:00, 14:00 and 16:00 minus the maximum intraocular pressure measured at 15 minute intervals over 45 minutes during the water drinking test.

Time frame: Single measurement (mDCT 5 measurements taken one every 2 hours and WDT a measurement taken every 15 minutes up to 45 minutes)

ArmMeasureValue (MEAN)Dispersion
Glaucoma PatientsMaximum Intraocular Pressure Difference (Between mDCT and WDT)-0.82 mmHgStandard Deviation 2.06

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026